DK0498784T3 - Hæmmere af retroviral protease - Google Patents

Hæmmere af retroviral protease

Info

Publication number
DK0498784T3
DK0498784T3 DK92870021.0T DK92870021T DK0498784T3 DK 0498784 T3 DK0498784 T3 DK 0498784T3 DK 92870021 T DK92870021 T DK 92870021T DK 0498784 T3 DK0498784 T3 DK 0498784T3
Authority
DK
Denmark
Prior art keywords
inhibitors
protease
retroviral protease
retroviral
coch2
Prior art date
Application number
DK92870021.0T
Other languages
English (en)
Inventor
Mihaly Vadkerti Toth
Garland Ross Marshall
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Application granted granted Critical
Publication of DK0498784T3 publication Critical patent/DK0498784T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK92870021.0T 1991-02-07 1992-02-06 Hæmmere af retroviral protease DK0498784T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/652,163 US5086165A (en) 1989-03-08 1991-02-07 Inhibitors of retroviral protease with a ketomethylene isosteric replaced amide bond

Publications (1)

Publication Number Publication Date
DK0498784T3 true DK0498784T3 (da) 1997-10-27

Family

ID=24615760

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92870021.0T DK0498784T3 (da) 1991-02-07 1992-02-06 Hæmmere af retroviral protease

Country Status (7)

Country Link
US (1) US5086165A (da)
EP (1) EP0498784B1 (da)
JP (1) JPH0565230A (da)
AT (1) ATE154036T1 (da)
CA (1) CA2060785A1 (da)
DE (1) DE69220100T2 (da)
DK (1) DK0498784T3 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554728A (en) * 1991-07-23 1996-09-10 Nexstar Pharmaceuticals, Inc. Lipid conjugates of therapeutic peptides and protease inhibitors
JPH07504654A (ja) * 1992-03-11 1995-05-25 ナルヘックス　リミテッド オキソ及びヒドロキシ置換炭化水素のアミン誘導体
DE69333270T2 (de) 1992-03-11 2004-08-05 Narhex Ltd. Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
CA2091151A1 (en) * 1992-03-13 1993-09-14 Kwan Y. Hui Retroviral protease inhibitors
US5364961A (en) * 1992-06-15 1994-11-15 Monsanto Company Process for making optically active α-amino ketones
US5559256A (en) * 1992-07-20 1996-09-24 E. R. Squibb & Sons, Inc. Aminediol protease inhibitors
US5473092A (en) * 1992-11-20 1995-12-05 Monsanto Company Synthesis of optically-active phosphono analogs of succinates
IL111991A (en) * 1994-01-28 2000-07-26 Abbott Lab Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent
US6222043B1 (en) 1995-06-30 2001-04-24 Japan Energy Corporation Methods of preparing novel dipeptide compounds or pharmaceutically acceptable salts thereof
US5932550A (en) * 1995-06-30 1999-08-03 Japan Energy Corporation Dipeptide compound or pharmaceutically acceptable salt thereof and medical use thereof
US5872210A (en) * 1995-10-05 1999-02-16 The United States Of America As Represented By The Department Of Health And Human Services Transframe peptide inhibitor of viral protease
US5747526A (en) * 1996-01-25 1998-05-05 Hollinshead; Ariel C. Anti-HIV /Aids Chemo(C)-, immuno(I)-, or ci-therapy using tur (or related compounds) and/or NVA (or EPV)
CA2249747A1 (en) 1996-12-27 1998-07-09 Tsutomu Mimoto Novel tripeptide compounds and anti-aids drugs
US7141593B1 (en) * 1999-06-04 2006-11-28 Abbott Laboratories Pharmaceutical formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880779A (en) * 1987-07-31 1989-11-14 Research Corporation Technologies, Inc. Method of prevention or treatment of AIDS by inhibition of human immunodeficiency virus
US5342922A (en) * 1989-03-08 1994-08-30 Washington University Inhibitors of retroviral protease

Also Published As

Publication number Publication date
CA2060785A1 (en) 1992-08-08
EP0498784A3 (en) 1993-03-31
DE69220100T2 (de) 1998-01-02
JPH0565230A (ja) 1993-03-19
US5086165A (en) 1992-02-04
EP0498784B1 (en) 1997-06-04
ATE154036T1 (de) 1997-06-15
EP0498784A2 (en) 1992-08-12
DE69220100D1 (de) 1997-07-10

Similar Documents

Publication Publication Date Title
DK0387231T3 (da) Hidtil ukendte inhibitorer for retroviral protease
DE69220100D1 (de) Retrovirale Protease-Inhibitoren
DK0774971T3 (da) Syntetiske peptid-inhibitorer for HIV-overförsel
EA199700331A1 (ru) Тгф-содержащие сульфонамидные ингибиторы аспартил-протеазы
NO974148L (no) Aminosyrehydroksyetylaminosulfonamid retrovirale proteaseinhibitorer
ATE335813T1 (de) Protease varianten
ATE148113T1 (de) Retrovirale protease inhibitoren, enthaltend cyclische sulfone
EA199700220A1 (ru) Замещенный бис-аминокислотой гидроксиэтиламиносульфонамид в качестве ингибиторов ретровирусной протеазы
EE04340B1 (et) Sulfonüülalkanoüülamino-hüdroksüetüülamino-sulfoonamiidsed retroviirusliku proteaasi inhibiitorid
IT1227907B (it) Procedimento per la sintesi di peptidi retro-inversi e nuovi intermediin tale procedimento
DK0552240T3 (da) Ny metode til behandling af depression
DK3688A (da) Pankreatisk sekretorisk trypsininhibitor og varianter deraf fremstillet af en rekombinant vaert, fremgangsmaade, ekspressionsvektor og rekombinant vaert samt farmaceutisk anvendelse deraf
ATE309264T1 (de) Peptidyl-2-amino-1hydroxyalkansulfonsäuren als cystein-protease-inhibitoren
NO914158D0 (no) En ny protease
DK0896615T3 (da) Peptid fra opløselig form af acetylcholinesterase, der er aktivt som calcium-kanal-modulator
DK1908772T3 (da) Polypeptider og polynucleinsyrer af phorphorymonas gingivalis
DK0437556T3 (da) Substitutionsanaloger af magaininpeptider
ATE211719T1 (de) Korrosionsinhibitoren enthaltender injektionszement
ES539382A0 (es) Procedimiento para la determinacion de fibrina
ATE147405T1 (de) Analoge von peptrolsubstraten
ES2083387T3 (es) Peptidos sinteticos y sus mezclas para la deteccion de anticuerpos hiv.
DK0463053T3 (da) Fremstilling og anvendelse af anthelmintiske midler og beskyttende immunogener
DK450187D0 (da) Fremgangsmaade til fremstilling af proteiner